Skip to main content
NCBI home page
The Journal of Hygiene logoLink to The Journal of Hygiene
. 1983 Dec;91(3):421–427. doi: 10.1017/s0022172400060459

A cephalosporin active in vivo against Nocardia: efficacy of cefotaxime in murine model of acute pulmonary nocardiosis.

A M Sugar, R S Chahal, D A Stevens
PMCID: PMC2129341  PMID: 6319484

Abstract

Cefotaxime, a cephalosporin drug, has been shown to be active in vitro against nocardiae, a finding confirmed in this study. Pharmacokinetic studies were performed in mice to define regimens which provided peak serum levels comparable to that achieved in man with currently used doses. These regimens were shown to be effective with only short courses of therapy of rapidly progressive and highly lethal N. asteroides infection, produced by pulmonary challenge of mice. This suggests the possible utility of this drug in human nocardiosis.

Full text

PDF
421

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach M. C., Gold O., Finland M. Activity of minocycline against Nocardia asteroides: comparison with tetracycline in agar-dilution and standard disc-diffusion tests and with sulfadiazine in an experimental infection of mice. J Lab Clin Med. 1973 May;81(5):787–793. [PubMed] [Google Scholar]
  2. Bach M. C., Sabath L. D., Finland M. Susceptibility of Nocardia asteroides to 45 antimicrobial agents in vitro. Antimicrob Agents Chemother. 1973 Jan;3(1):1–8. doi: 10.1128/aac.3.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beaman B. L., Goldstein E., Gershwin M. E., Maslan S., Lippert W. Lung response to congenitally athymic (nude), heterozygous, and Swiss Webster mice to aerogenic and intranasal infection by Nocardia asteroides. Infect Immun. 1978 Dec;22(3):867–877. doi: 10.1128/iai.22.3.867-877.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beaman B. L., Maslan S., Scates S., Rosen J. Effect of route on inoculation on host resistance to Nocardia. Infect Immun. 1980 Apr;28(1):185–189. doi: 10.1128/iai.28.1.185-189.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Beaman B. L. Structural and biochemical alterations of Nocardia asteroides cell walls during its growth cycle. J Bacteriol. 1975 Sep;123(3):1235–1253. doi: 10.1128/jb.123.3.1235-1253.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Carroll G. F., Brown J. M., Haley L. D. A method for determining in-vitro drug susceptibilities of some Nocardiae and Actinomadurae: results with 17 antimicrobial agents. Am J Clin Pathol. 1977 Aug;68(2):279–283. doi: 10.1093/ajcp/68.2.279. [DOI] [PubMed] [Google Scholar]
  7. Cook F. V., Farrar W. E., Jr Treatment of Nocardia asteroides infection with trimethoprim-sulfamethoxazole. South Med J. 1978 May;71(5):512–515. doi: 10.1097/00007611-197805000-00011. [DOI] [PubMed] [Google Scholar]
  8. Cynamon M. H., Palmer G. S. In vitro susceptibility of Nocardia asteroides to N-formimidoyl thienamycin and several cephalosporins. Antimicrob Agents Chemother. 1981 Dec;20(6):841–842. doi: 10.1128/aac.20.6.841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Epstein E. Treatment of a cutaneous Nocardia asteroides infection with minocycline hydrochloride. West J Med. 1974 Jun;120(6):497–499. [PMC free article] [PubMed] [Google Scholar]
  10. Finland M., Bach M. C., Garner C., Gold O. Synergistic action of ampicillin and erythromycin against Nocardia asteroides: effect of time of incubation. Antimicrob Agents Chemother. 1974 Mar;5(3):344–353. doi: 10.1128/aac.5.3.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Galgiani J. N., Stevens D. A. Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size. Antimicrob Agents Chemother. 1976 Oct;10(4):721–728. doi: 10.1128/aac.10.4.721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. García-Rodríguez J. A., Gómez-García A. C., Aguero J., García-Sanchez J. E. In-vitro susceptibility of Nocardia and Rhodococcus to fourteen beta-lactam antibiotics. J Antimicrob Chemother. 1982 Dec;10(6):564–565. doi: 10.1093/jac/10.6.564. [DOI] [PubMed] [Google Scholar]
  13. Gombert M. E. Susceptibility of Nocardia asteroides to various antibiotics, including newer beta-lactams, trimethoprim-sulfamethoxazole, amikacin, and N-formimidoyl thienamycin. Antimicrob Agents Chemother. 1982 Jun;21(6):1011–1012. doi: 10.1128/aac.21.6.1011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jones R. N., Thornsberry C. Cefotaxime: a review of in vitro antimicrobial properties and spectrum of activity. Rev Infect Dis. 1982 Sep-Oct;4 (Suppl):S300–S315. doi: 10.1093/clinids/4.supplement_2.s300. [DOI] [PubMed] [Google Scholar]
  15. Karakusis P. H., Feczko J. M., Goodman L. J., Hanlon D. M., Harris A. A., Levin S., Trenholme G. M. Clinical efficacy of cefotaxime in serious infections. Antimicrob Agents Chemother. 1982 Jan;21(1):119–124. doi: 10.1128/aac.21.1.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Maderazo E. G., Quintiliani R. Treatment of nocardial infection with trimethoprim and sulfamethoxazole. Am J Med. 1974 Oct;57(4):671–675. doi: 10.1016/0002-9343(74)90022-9. [DOI] [PubMed] [Google Scholar]
  17. Smith P. W., Steinkraus G. E., Henricks B. W., Madson E. C. CNS nocardiosis: response to sulfamethoxazole-trimethoprim. Arch Neurol. 1980 Nov;37(11):729–730. doi: 10.1001/archneur.1980.00500600077017. [DOI] [PubMed] [Google Scholar]
  18. Wallace R. J., Jr, Septimus E. J., Musher D. M., Berger M. B., Martin R. R. Treatment of experimental nocardiosis in mice: comparison of amikacin and sulfonamide. J Infect Dis. 1979 Aug;140(2):244–248. doi: 10.1093/infdis/140.2.244. [DOI] [PubMed] [Google Scholar]
  19. Wallace R. J., Jr, Septimus E. J., Musher D. M., Martin R. R. Disk diffusion susceptibility testing of Nocardia species. J Infect Dis. 1977 Apr;135(4):568–576. doi: 10.1093/infdis/135.4.568. [DOI] [PubMed] [Google Scholar]
  20. Wallace R. J., Jr, Septimus E. J., Williams T. W., Jr, Conklin R. H., Satterwhite T. K., Bushby M. B., Hollowell D. C. Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia. Rev Infect Dis. 1982 Mar-Apr;4(2):315–325. doi: 10.1093/clinids/4.2.315. [DOI] [PubMed] [Google Scholar]
  21. Wren M. V., Savage A. M., Alford R. H. Apparent cure of intracranial Nocardia asteroides infection by minocycline. Arch Intern Med. 1979 Feb;139(2):249–250. [PubMed] [Google Scholar]
  22. Yogev R., Greenslade T., Firlit C. F., Lewy P. Successful treatment of Nocardia asteroides infection with amikacin. J Pediatr. 1980 Apr;96(4):771–773. doi: 10.1016/s0022-3476(80)80766-9. [DOI] [PubMed] [Google Scholar]
  23. Young L. S., Armstrong D., Blevins A., Lieberman P. Nocardia asteroides infection complicating neoplastic disease. Am J Med. 1971 Mar;50(3):356–367. doi: 10.1016/0002-9343(71)90224-5. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Hygiene are provided here courtesy of Cambridge University Press

RESOURCES